hotspot -WSS

hotspot

author：fashion 2025-09-07 21:56:24 - browse：88

Astrazeneca office building -- health policy coverage from STAT — AstraZeneca is suing the Biden administration to stop a new Medicare drug price negotiation program. Adobe

WASHINGTON — AstraZeneca is the sixth drugmaker to pile on a legal challenge to the Biden administration’s drug pricing reform law.

The Medicare drug price negotiation program created in the Inflation Reduction Act is set to kick off in the next week, as officials will release the names of the first 10 medicines that will be selected for the program. Medicines are eligible for selection if they are one of the highest-spend drugs for Medicare, and they have no generic competition.

AstraZeneca makes drugs that could be selected for the list, and asked a Delaware district court judge to rule that Medicare acted illegally and that the law is unconstitutional.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Chimpanzees, like humans and whales, get menopause: Study

WSS

Traditional Chinese medicine benefits explored in new JAMA study

Eli Lilly to pay $200M for Beam’s stake in gene

US jobless claims fall again as labor market continues to flash strength

Physician subsidies by hospitals soar in wake of No Surprises Act

Testing for cancer recurrence creates a new limbo for patients

There’s a way to spot data fakery. All journals should be using it

hotspot

hotspot

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Testing for cancer recurrence creates a new limbo for patients

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Diversifying clinical trials isn't enough to close racial gaps: study

At least 13 dead in Texas as scorching temps continue

Diversifying clinical trials isn't enough to close racial gaps: study

In Memoriam: Notable people who died in 2023

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Readout Newsletter: What happened with Sarepta's Duchenne data

entertainment

Telehealth startups are trying to fill the menopause care vacuum

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Biden's order seeks to regulate AI risk without stifling innovation

How a Boston hospital is priming medical residents to use GPT

Emergency medicine has repudiated 'excited delirium.' Now what?

Diversifying clinical trials isn't enough to close racial gaps: study

explore

leisure time

explore

leisure time